BOCA RATON, Fla., Oct. 19 /PRNewswire-FirstCall/ -- Stem Cell Assurance, Inc. (Pink Sheets: SCLZ) announced today the appointment of Mark Weinreb as Chief Executive Officer and as a member of the Company's Board of Directors. Mr. Weinreb is a well-recognized and respected professional within the medical and financial communities.
Mr. Weinreb offers expertise in public (President and CEO of AMEX and NASDAQ listed companies) and private corporate management, in the areas of healthcare, medical devices, research programs, franchising, and business/product development. Mr. Weinreb was most recently President and a director of NeoStem, Inc., a public biotechnology medical services company specializing in enhancing the delivery of adult stem cell therapeutics and developing an international network of adult stem cell collection centers.
Mr. Weinreb also was an owner and operator of BioHealth Laboratories, Inc., a leading diagnostic state-of-the-art medical laboratory providing clinical testing services for physicians, hospitals, and other medical laboratories. He was educated at Northwestern University and C.W. Post (Long Island University).
Gloria McConnell, President of Stem Cell Assurance, stated, "We are extremely pleased and fortunate to have a seasoned entrepreneur and executive of Mr. Weinreb's caliber become so excited about our Company that he has accepted our offer to become our full time chief executive officer and provide his leadership skills in growing the Company's business."
Said Mr. Weinreb, "I believe the Company's business has tremendous potential, and I very much look forward to embarking on an aggressive growth strategy that will position the Company to capitalize on current and future therapeutic uses of adult stem cells."
About Stem Cell Assurance, Inc.
Stem Cell Assurance, Inc.'s goal is to
|SOURCE Stem Cell Assurance, Inc.|
Copyright©2010 PR Newswire.
All rights reserved